U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those th...
Merck Life Science in India announced the signing of a Memorandum of Understanding (MoU) with Aragen Life Sciences, a leading provider of R&D a...
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...
To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...
NurExone Biologic Inc, a pioneering biopharmaceutical company, is thrilled to announce an important milestone in its regenerative medicine efforts. The C...
Agilent announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, f...
The Biosecure Act is a significant legislative proposal aimed at reshaping the pharmaceutical supply chain landscape, particularly concerning the s...
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media Supports local biopharma manufact...
CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...
Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing faci...
ChargePoint Technology, a leading specialist in powder containment and aseptic transfer solutions, is expanding its presence in India, and announced...
Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...
Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, andArgonaut...
• Consortium formed between WACKER & CordenPharma has officially entered the pandemic readiness state as of 1 June 2024 to produ...
© 2025 Biopharma Boardroom. All Rights Reserved.
